Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate ARTHRITIS & RHEUMATOLOGY Kivitz, A. J., Gutierrez-Urena, S. R., Poiley, J., Genovese, M. C., Kristy, R., Shay, K., Wang, X., Garg, J. P., Zubrzycka-Sienkiewicz, A. 2017; 69 (4): 709-719
View details for DOI 10.1002/art.39955
View details for Web of Science ID 000397615900003